Skip to content

A multi-center clinical study on the treatment of knee osteoarthritis with Qubi Yangge Decoction combined with three steps and nine methods of whole knee

A multi-center clinical study on the treatment of knee osteoarthritis with Qubi Yangge Decoction combined with three steps and nine methods of whole knee

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036077
Enrollment
Unknown
Registered
2020-08-21
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Treatment group:???

Sponsors

Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of knee osteoarthritis and TCM syndrome differentiation standards; 2. Patients who voluntarily receive drug treatment; 3. Patients who have not taken other drugs for knee osteoarthritis 2 weeks before treatment; 4. Informed consent form has been signed and guaranteed Patients who have completed the course of treatment.

Exclusion criteria

Exclusion criteria: 1. Those who do not meet the diagnostic criteria of Western medicine for knee osteoarthritis and the criteria of TCM syndrome differentiation; 2. Those under the age of 40; 3. Women who are breastfeeding or preparing to become pregnant; 4. Those with allergies and allergies to multiple drugs; 5. With liver, kidney, Patients with primary diseases such as hematopoietic system and endocrine system and mental illness; 6. those who are critically ill and should be treated with surgery; 7. mentally or legally disabled; 8. suspected to have a history of alcohol or drug abuse, or according to judgment, have reduced income Group possibility or other medical history that complicates the enrollment, such as frequent changes in the work environment, which may easily lead to loss of follow-up; 9. Subjects who are participating in clinical studies of other drugs; 10. In critical condition, it is difficult to determine the effectiveness and safety of the drug The person who makes an accurate assessment of sex.

Design outcomes

Primary

MeasureTime frame
VAS score;WOMAC Osteoarthritis Index Questionnaire Survey;SF-36 score;Knee joint circumference;X-ray;

Countries

China

Contacts

Public ContactJinhai Xu

Shanghai University of Traditional Chinese Medicine

jinhaixu@126.com+86 18016006692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026